You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

Drug Sales Trends for DOXYCYCLINE

✉ Email this page to a colleague

« Back to Dashboard

Payment Methods and Pharmacy Types for DOXYCYCLINE (2021)

Revenues by Pharmacy Type

Chart
Table

Pharmacy Type	Revenues
MAIL-ORDER	$47,448,408
INSIDE ANOTHER STORE	$7,981,898
[disabled in preview]	$46,456,052
This preview shows a limited data set Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Chart
Table

Pharmacy Type	Units
MAIL-ORDER	428,832
INSIDE ANOTHER STORE	421,880
[disabled in preview]	596,951
This preview shows a limited data set Subscribe for full access, or try a Trial

Revenues by Payment Method

Chart
Table

Payment Method	Revenues
MEDICARE	$38,543,071
PRIVATE INSURANCE	$18,824,235
[disabled in preview]	$44,519,051
This preview shows a limited data set Subscribe for full access, or try a Trial

Drug Sales Revenue Trends for DOXYCYCLINE

Drug Units Sold Trends for DOXYCYCLINE

Annual Sales Revenues and Units Sold for DOXYCYCLINE

These sales figures are drawn from a US national survey of drug expenditures

Subscribe to access the full database, or Subscribe
Drug Name	Revenues (USD)	Units	Year
DOXYCYCLINE	⤷ Subscribe	⤷ Subscribe	2021
DOXYCYCLINE	⤷ Subscribe	⤷ Subscribe	2020
DOXYCYCLINE	⤷ Subscribe	⤷ Subscribe	2019
DOXYCYCLINE	⤷ Subscribe	⤷ Subscribe	2018
DOXYCYCLINE	⤷ Subscribe	⤷ Subscribe	2017
DOXYCYCLINE	⤷ Subscribe	⤷ Subscribe	2016
>Drug Name	>Revenues (USD)	>Units	>Year

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.